Ignoring adverse experiences of people taking statinsBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2030 (Published 12 April 2016) Cite this as: BMJ 2016;353:i2030
- Thomas L Perry, physician
- Department of Medicine, UBC Hospital, Vancouver, Canada V6T 2B5
In primary prevention trials statins slightly reduce atherosclerotic events but not total serious adverse events.1 Another paradox is that many patients have muscle pain, fatigue, or weakness that resolves when they stop the drug, yet clinical trialists do not believe in a causal association.
Francis and Cole assert that statins cause no more …